TCL Archive NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances? April 21, 1995
TCL Archive Younger Patients, More Advanced Stages, More Likely To Die From Breast Cancer September 24, 2004
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
